The Calcineurin Inhibitor Tacrolimus as a New Therapy in Severe Cherubism

Autoinflammatory bone disorders

(2013) Henner Morbach et al.   CLINICAL IMMUNOLOGY

Anti-tumor necrosis factor treatment in cherubism — Clinical, radiological and histological findings in two children

(2012) M. Hero et al.   BONE

Cherubism: best clinical practice

(2012) Maria E Papadaki et al.   Orphanet Journal of Rare Diseases

Nocturnal mouthpiece ventilation and medical hypnosis to treat severe obstructive sleep apnea in a child with cherubism

(2012) Sonia Khirani et al.   PEDIATRIC PULMONOLOGY

Tankyrase Loses Its Grip on SH3BP2 in Cherubism

(2011) Agnes D. Berendsen et al.   CELL

Cherubism gene Sh3bp2 is important for optimal bone formation, osteoblast differentiation, and function

(2010) Padma M. Mukherjee et al.   AMERICAN JOURNAL OF ORTHODONTICS AND DENTOFACIAL ORTHOPEDICS

NFATc1 and TNFα expression in giant cell lesions of the jaws

(2010) Fabrício Rezende Amaral et al.   JOURNAL OF ORAL PATHOLOGY & MEDICINE

Unexpected matrix diseases and novel therapeutic strategies

(2009) Claudia Nicolae et al.   CELL AND TISSUE RESEARCH

NFATc1: Functions in osteoclasts

(2009) Qingxiao Zhao et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

SH3BP2 is an activator of NFAT activity and osteoclastogenesis

(2008) Steven A. Lietman et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism

(2008) Antonios O. Aliprantis et al.   JOURNAL OF CLINICAL INVESTIGATION

NFATc1 Induces Osteoclast Fusion Via Up-Regulation of Atp6v0d2 and the Dendritic Cell-Specific Transmembrane Protein (DC-STAMP)

(2007) Kabsun Kim et al.   MOLECULAR ENDOCRINOLOGY